PET studies in healthy volunteers using [11C]raclopride (51) as well as in patients with schizophrenia using [18F]Fallypride (52) aripiprazole with D2R preference showed dose-dependent occupancy in the D2R-rich striatum without causing extrapyramidal side effects. Here, DRD2 is linked to schizophrenia.